BNTC vs VRTX · $388.7M cap vs P/E 30, rev $3.33B
Benitec Biopharma Ltd ADR (BNTC) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Benitec Biopharma Ltd ADR (BNTC) is a biotechnology company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported BNTC revenue for 2026-03-31 was $0. Net income was -$32.7M. BNTC currently screens at market cap $388.7M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BNTC currently screens at market cap $388.7M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BNTC and VRTX stock pages for the full models.
Not investment advice.